Birch bark extract (Filsuvez®). HTA ID: 23069

Assessment Status Awaiting full HTA submission from Applicant
HTA ID 23069
Drug Birch bark extract
Brand Filsuvez®
Indication Treatment of partial thickness wounds associated with dystrophic and junctional epidermolysis bullosa (EB) in patients 6 months and older.
Assessment Process
Rapid review commissioned 10/11/2023
Rapid review completed 08/12/2023
Rapid review outcome A full HTA is recommended to assess the clinical effectiveness and cost effectiveness of birch bark extract compared with the current standard of care.
Full pharmacoeconomic assessment commissioned by HSE 18/12/2023
Pre-submission consultation with Applicant 23/04/2024